LEADER 01775nas 2200601-a 450 001 996215269503316 005 20240203213017.0 011 $a1424-3210 035 $a(DE-599)ZDB2052857-7 035 $a(OCoLC)47250782 035 $a(CKB)111075993724062 035 $a(CONSER)--2002242115 035 $a(EXLCZ)99111075993724062 100 $a20010706a20019999 s-- - 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aSensors 210 $aBasel, Switzerland $cMolecular Diversity Preservation International (MDPI)$dİ2000- 215 $a1 online resource 300 $aRefereed/Peer-reviewed 300 $aTitle from tables of contents page (viewed August 14, 2002). 311 $a1424-8220 517 1 $aSensor 531 $aSENSORS BASEL SENSORS 531 $aSENSORS-BASEL 531 $aSENSORS (BASEL) 531 $aBASEL 531 00$aSensors 606 $aDetectors$vPeriodicals 606 $aBiosensors$vPeriodicals 606 $aChemical detectors$vPeriodicals 606 $aBiosensing Techniques 606 $aBiosensors$2fast$3(OCoLC)fst00832703 606 $aChemical detectors$2fast$3(OCoLC)fst00852873 606 $aDetectors$2fast$3(OCoLC)fst00891594 608 $aPeriodical. 608 $aPeriodicals.$2fast 608 $aPeriodicals.$2lcgft 615 0$aDetectors 615 0$aBiosensors 615 0$aChemical detectors 615 12$aBiosensing Techniques. 615 7$aBiosensors. 615 7$aChemical detectors. 615 7$aDetectors. 712 02$aMolecular Diversity Preservation International. 906 $aJOURNAL 912 $a996215269503316 996 $aSensors$9114301 997 $aUNISA LEADER 03715nam 22006135 450 001 9910253944103321 005 20200706133441.0 010 $a3-319-65720-8 024 7 $a10.1007/978-3-319-65720-2 035 $a(CKB)4340000000223352 035 $a(DE-He213)978-3-319-65720-2 035 $a(MiAaPQ)EBC5154003 035 $a(PPN)221252630 035 $a(EXLCZ)994340000000223352 100 $a20171122d2017 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aIn Vivo Reprogramming in Regenerative Medicine /$fedited by Açelya Yilmazer 205 $a1st ed. 2017. 210 1$aCham :$cSpringer International Publishing :$cImprint: Humana,$d2017. 215 $a1 online resource (XVII, 103 p. 15 illus. in color.) 225 1 $aStem Cell Biology and Regenerative Medicine,$x2196-8985 311 $a3-319-65719-4 327 $aChapter 1. Introduction to in vivo cell Reprogramming Technology -- Chapter 2. In vivo Reprogramming for Regenerating Insulin-Secreting Cells -- Chapter 3. Direct Reprogramming to Beta Cells -- Chapter 4. In vivo Lineage Reprogramming of Fibroblasts to Cardiomyocytes for Heart Regeneration -- Chapter 5: In vivo cell Reprogramming for Long-term Pluripotency -- Chapter 6: In vivo Transient Reprogramming Towards Pluripotency for Tissue Repair and Regeneration -- Chapter 7. Challenges and Future Perspectives for in vivo Reprogramming Technology. 330 $aThere have been significant improvements in the development of cell based therapies; however, current treatment strategies still suffer from some problems: the need for long in vitro culture conditions, inefficient delivery of cells by scaffolds and low incorporation and grafting efficiencies. Therefore, in vivo reprogramming has emerged as a novel treatment technology. In the process of in vivo reprogramming, cells switch to another cell type within the living organism. Leaders in the field discuss how in vivo reprogramming can be used for tissue repair and regeneration in different organs, including pancreas, liver and heart. Furthermore, recent studies on in vivo cell reprogramming towards pluripotency are also reviewed. Current challenges of these preclinical studies are discussed and hypothesis and suggestions are given in order to improve the current strategies to achieve translation into clinic. . 410 0$aStem Cell Biology and Regenerative Medicine,$x2196-8985 606 $aRegenerative medicine 606 $aTissue engineering 606 $aStem cells 606 $aCell culture 606 $aSurgical transplantation 606 $aRegenerative Medicine/Tissue Engineering$3https://scigraph.springernature.com/ontologies/product-market-codes/L16080 606 $aStem Cells$3https://scigraph.springernature.com/ontologies/product-market-codes/L16010 606 $aCell Culture$3https://scigraph.springernature.com/ontologies/product-market-codes/L16020 606 $aTransplant Surgery$3https://scigraph.springernature.com/ontologies/product-market-codes/H59117 615 0$aRegenerative medicine. 615 0$aTissue engineering. 615 0$aStem cells. 615 0$aCell culture. 615 0$aSurgical transplantation. 615 14$aRegenerative Medicine/Tissue Engineering. 615 24$aStem Cells. 615 24$aCell Culture. 615 24$aTransplant Surgery. 676 $a612.028 676 $a571.538 702 $aYilmazer$b Açelya$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910253944103321 996 $aIn Vivo Reprogramming in Regenerative Medicine$92110405 997 $aUNINA